Overview
IASLC faculty members from Europe, Asia, and North America will discuss systemic therapies including chemotherapy, immunotherapy, and targeted therapy for advanced stage lung cancer during the COVID-19 global pandemic. The faculty will share their experience and advice on
- how COVID-19 impacts their patient population
- changes made in the management of current and newly diagnosed lung cancer patients due to pandemic, including starting and stopping treatment and monitoring
- testing for COVID-19
- outcomes of COVID-19 positive lung cancer patients.
Format: There will be two presentations followed by ample time for questions from the audience.
Date and Time: April 29, 2020 at 9:00AM EDT; 3:00PM CEST; 9:00PM HKT
Medical oncologists treating lung cancer patients, other clinical specialists involved in lung cancer care, and patients/patients advocates.
At the conclusion of this webinar, learners will have improved their ability to make treatment decisions for patients with advanced stage lung cancer during the COVID-19 pandemic.
Planning Chair:
Francisco Suarez, MD, Chile
Planning Committee Members:
Federico Cappuzzo, MD, Italy
Caicun Zhou, MD, PhD, China
Murry Wynes, PhD, United States
Chandra Belani, MD, United States
Kirsten Black, PhD, MPH, United States
For any inquiries, please contact [email protected].
Date and Time: April 29, 2020 at 9:00AM EDT; 3:00PM CEST; 9:00PM HKT
Medical oncologists treating lung cancer patients, other clinical specialists involved in lung cancer care, and patients/patients advocates.
At the conclusion of this webinar, learners will have improved their ability to make treatment decisions for patients with advanced stage lung cancer during the COVID-19 pandemic.
Planning Chair:
Francisco Suarez, MD, Chile
Planning Committee Members:
Federico Cappuzzo, MD, Italy
Caicun Zhou, MD, PhD, China
Murry Wynes, PhD, United States
Chandra Belani, MD, United States
Kirsten Black, PhD, MPH, United States
For any inquiries, please contact [email protected].
Share
Related Content
